January 17, 2022
An interview with David Suhy, the Chief Science Officer and cofounder of Earli, on synthetic biopsy, the benefits of working on medical tech in a commercial context, and more.
January 11, 2022
For the past two years, Earli has been working with a team at UC Davis to demonstrate the safety and efficacy of Earli’s breakthrough early cancer detection technology in canine patients.
January 10, 2022
An interview with Cyriac Roeding, the CEO and cofounder of Earli, on how he’s applying lessons from software development to a biotech company, the future of early cancer detection, and more.
July 21, 2021
Despite the progress made in treatment and prevention in recent years, cancer remains the number two killer in the United States after heart disease. The high mortality rates are largely due to the...
June 7, 2021
The Covid-19 pandemic has taken over 3.4 million lives worldwide since 2020. Every single one of these deaths is a tragedy. By comparison, each year around three times as many people will die...
May 26, 2021
Earli’s Scientific Advisory Board consists of some the brightest minds in oncology in the world, including directors of the world’s leading cancer research institutes and Nobel laureates for the
May 4, 2021
The global pandemic made the past year challenging in so many ways. But it’s important not to lose sight of the progress that was made in other areas despite the hardship.